Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis
Abstract Biologic agents (BA) are able to induce an adaptive immune response in a proportion of exposed patients with the onset of anti-drug antibodies (ADA), which are usually responsible for hypersensitivity reactions (HR). Drug desensitization (DD) for BA allows transient clinical tolerance to th...
Guardado en:
Autores principales: | Alessandra Vultaggio, Francesca Nencini, Susanna Bormioli, Elena Silvestri, Laura Dies, Emanuele Vivarelli, Enrico Maggi, Andrea Matucci |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9e52b0688aa4ef3b1e3b6c04744234c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Knowledge of healthcare providers in the management of anaphylaxis
por: Sandra Nora González-Díaz, MD, PhD, et al.
Publicado: (2021) -
Cognitive Systematic Desensitization
por: Malik B. Badri
Publicado: (2014) -
Anaphylaxis in new European Resuscitation Council guidelines 2021
por: Alihodžić Hajriz
Publicado: (2021) -
Identification of allergens for food-dependent exercise-induced anaphylaxis to shrimp
por: Shiori Akimoto, et al.
Publicado: (2021) -
Review of tocilizumab in the treatment of rheumatoid arthritis
por: Yasuaki Okuda
Publicado: (2008)